Foundry Partners’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,574
Closed -$334K 319
2023
Q3
$334K Sell
1,574
-650
-29% -$130K 0.02% 251
2023
Q2
$428K Hold
2,224
0.03% 253
2023
Q1
$450K Sell
2,224
-34
-2% -$5.45K 0.03% 248
2022
Q4
$290K Hold
2,258
0.02% 281
2022
Q3
$309K Buy
2,258
+582
+35% +$94.8K 0.02% 274
2022
Q2
$297K Buy
+1,676
New +$242K 0.02% 267
2022
Q1
Sell
-1,422
Closed -$220K 373
2021
Q4
$220K Hold
1,422
0.01% 338
2021
Q3
$241K Buy
1,422
+27
+2% +$4.2K 0.01% 345
2021
Q2
$220K Buy
+1,395
New +$207K 0.01% 359
2021
Q1
Sell
-1,395
Closed -$244K 452
2020
Q4
$244K Buy
1,395
+365
+35% +$68.1K 0.01% 405
2020
Q3
$202K Buy
+1,030
New +$172K 0.01% 406

Other funds holding SGEN

Foundry Partners's SGEN Position: Q4 2023 in Review

Foundry Partners sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 1,574 shares — an estimated $334K sold.

Foundry Partners first reported a position in SGEN in Q3 2020 and held it in 11 quarters. The position peaked at $450K in Q1 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Foundry Partners reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Foundry Partners sold 1,574 Seagen Inc. Common Stock shares in Q4 2023, an estimated $334K.
  • Foundry Partners first reported a position in Seagen Inc. Common Stock in Q3 2020 and held it in 11 quarters.
  • Foundry Partners's Seagen Inc. Common Stock position peaked at $450K in Q1 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Foundry Partners's 13F filing for Q4 2023, filed 1 Feb 2024.